The biomedicine and great health industries in Huai'an City showed a trend of innovation, breakthrough and vigorous development. According to the data, in 2024, there were 77 enterprises above designated size in Huai'an city's biomedicine and great health industries, with invoice sales reaching RMB 22.78 billion, up 3.3% year-on-year, accounting for 6.04% of the total of all industries above designated size.

In recent years, Huai'an City has attached great importance to the development of biomedicine and great health industry. It continuously plays the role of industrial guidance and dual subjects of enterprises and schools, integrates the best resources of the national biomedical industry, builds a new ecology for high-quality talent development in the biomedical industry, and injects new impetus into the integration of production and education and talent training in the biomedical industry.

In terms of construction of carriers, there are 2 biomedical related parks in Huai'an City, namely the Huai'an Biomedical Industrial Park in Qingjiangpu District and the Huai'an Industrial Park. At present, 8 biomedical enterprises and medical device manufacturers such as Chiatai Qingjiang Pharmaceutical Co., Ltd (CTQJ) and Tasly Diyi Pharmaceutical Co., Ltd have settled in Huai'an Biomedical Industrial Park, with annual invoice sales revenue accounting for more than 75% of the city's pharmaceutical industry. Huai'an Industrial Park has been recognized as a provincial-level chemical park. At present, there are 5 chemical pharmaceutical raw material production enterprises such as Willing Bio-Tech Co., Ltd and Run'an Pharmaceuticals in the park, and the park has become the main supply park for raw materials required for chemical drug production in Huai'an City.

According to statistics, in 2024, there were 27 enterprises above designated size in the biomedical industry in Huai'an City, with an invoice issuance of RMB 3.14 billion, up 3.86% year-on-year; There were 13 enterprises above designated size in the medical device industry, with an invoice amount of RMB 970 million and a year-on-year increase of 11.3%; There were 37 enterprises above designated size in the biological health industry, with taxable invoices of RMB 18.67 billion, up 2.87% year-on-year.